Characterizing hepatitis B virus infection in children in the Democratic Republic of Congo to inform elimination efforts
Author:
Morgan CE,Powers KA,Edwards JK,Devkota U,Biju S,Lin FC,Schmitz JL,Cloherty G,Muwonga J,Mboyo A,Tshiamala P,Kashamuka MM,Tshefu A,Emch M,Yotebieng M,Becker-Dreps S,Parr JB,Thompson P
Abstract
AbstractObjectiveDespite global reductions in hepatitis B virus (HBV) prevalence, an estimated 6.2 million children are infected, two-thirds of whom live in the WHO Africa region. We sought to characterize childhood HBV to inform elimination efforts in the Democratic Republic of Congo (DRC), one of the largest and most populous African countries.MethodsUsing the most recent (2013–14) nationally representative Demographic and Health Survey in the DRC, we analyzed HBV surface antigen (HBsAg) on dried blood spots and associated survey data from children aged 6-59 months. We estimated HBsAg-positivity prevalence nationally, regionally, and by potential correlates of infection. We evaluated spatial variation in HBsAg-positivity prevalence, overall and by age, sex, and vaccination status.FindingsUsing data from 5,679 children, we found national HBsAg-positivity prevalence was 1.3% (95% CI: 0.9%-1.7%), but ranged from 0.0% in DRC’s capital city province, Kinshasa, to 5.6% in northwestern Sud-Ubangi Province. Prevalence among boys (1.8%, 95% CI: 1.2%-2.7%) was double that among girls (0.7%, 95%CI: 0.4%-1.3%). Tetanus antibody-negativity, rurality, and lower household wealth were also significantly associated with higher HBsAg-positivity prevalence. We observed no difference in prevalence by age. Children had higher HBsAg-positivity odds if living with ≥1 HBsAg-positive adult household member (OR: 2.3, 95%CI: 0.7-7.8), particularly an HBsAg-positive mother (OR: 7.2, 95%CI:1.6-32.2).ConclusionIn the largest national survey of HBV among children and household contacts in the DRC, we found that childhood HBV prevalence was 10-60 times the global target of 0.1%. We highlight specific regions and populations for further investigation and focused prevention efforts.
Publisher
Cold Spring Harbor Laboratory
Reference47 articles.
1. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016- 2021: actions for impact: web annex 1: key data at a glance [Internet]. Geneva: World Health Organization
2. 2021 [cited 2021 Oct 12]. 11 p. Available from: https://apps.who.int/iris/handle/10665/342808
3. CDC. Centers for Disease Control and Prevention 2020 [cited 2021 Jun 14]. Hepatitis B FAQs | CDC. Available from: https://www.cdc.gov/hepatitis/hbv/bfaq.htm
4. World Health Organization. Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy [Internet]. Geneva: World Health Organization; 2020 [cited 2022 Nov 20]. 41 p. Available from: https://apps.who.int/iris/handle/10665/333391
5. Mother-to-child transmission of hepatitis B in sub-Saharan Africa;Lancet Infect Dis,2016